2-year-old in Wyoming may lose both eyes to FEVR

Article

A young girl in Wyoming has already lost one eye to familial exudative vitreo-retinopathy (FEVR) and may soon lose the other.

A young, two-year-old girl in Wyoming had her left eye surgically removed when she was two months old and is close to losing her right eye as well. The girl has been diagnosed with familial exudative vitreo-retinopathy (FEVR).

"FEVR is a life-long potentially active retinal vascular disease that can lead to a combined exudative and tractional retinal detachment due to untreated VEGF," according to Michael T. Trese, MD, in an article on Ophthalmology Times about anti-VEGF therapy for children.

The girl, Elly Bingham, has gone through three prosthetic eyes and will be getting a fourth one soon. The girl's parents seem to be having issues with purchasing the larger prosthetics when she grows out of them (they come at about $1,000 an eye). The family's insurance doesn't cover the pieces because they're considered cosmetic. Elly also needs to be taken from home in Cheyenne to Denver at least twice a week for checkups, laser surgery, and to go to an early education school for the visually impaired.

According to her teacher, JC Greenly at the Anchor Center, Elly handles her condition well,

"“She’s boss of the world, pretty much. She’s very independent, and at the same time, pretty social. She knows what she wants, and she’s also very curious about what she does see.”

Read more about Elly and her fight with FEVR at the Wyoming Tribune Eagle.


You May Also Be Interested In…

Mixed results seen with anti-VEGF therapy for children's retinal diseases

Anti-VEGF therapy targets certain retinal vascular diseases

Gene therapy still years away

ROP a lifelong disease that needs to be monitored

Glaucoma is key area of genetic research

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
Dr Ashley Tucker Wallace discusses the intersection of pediatric dry eye and myopia control
© 2025 MJH Life Sciences

All rights reserved.